Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Obstructive Lung Diseases

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 220 articles:
HTML format



Single Articles


    March 2024
  1. GUPTA S, Couillard S, Digby G, Tse SM, et al
    Climate Change and Inhaler Selection in Patients With Respiratory Disease.
    Chest. 2024;165:503-506.
    PubMed    


  2. SAHAY S
    Rebuttal From Dr Sahay.
    Chest. 2024;165:498-499.
    PubMed    


  3. BINEY IN, Ari A, Barjaktarevic IZ, Carlin B, et al
    Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.
    Chest. 2024;165:653-668.
    PubMed     Abstract available


  4. HE D, Yan M, Zhou Y, Ge H, et al
    Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
    Chest. 2024;165:573-582.
    PubMed     Abstract available


    February 2024
  5. THOMAS D, McDonald VM, Stevens S, Baraket M, et al
    Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
    Chest. 2024 Feb 29:S0012-3692(24)00284-8. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  6. LEE TY, Price D, Yadav CP, Roy R, et al
    International variation in severe exacerbation rates in patients with severe asthma.
    Chest. 2024 Feb 21:S0012-3692(24)00264-2. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  7. GODET C, Brun AL, Couturaud F, Laurent F, et al
    CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
    Chest. 2024 Feb 20:S0012-3692(24)00261-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  8. WU TD, Diamant Z, Hanania NA
    An Update on Patient-Reported Outcomes in Asthma.
    Chest. 2024 Feb 14:S0012-3692(24)00156-9. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  9. CORDEIRO R, Choi H, Haworth CS, Chalmers JD, et al
    The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: Updated systematic review and meta-analysis.
    Chest. 2024 Feb 1:S0012-3692(24)00139-9. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  10. MCINTOSH MJ, Hofmann JJ, Kooner HK, Eddy RL, et al
    (129)Xe MRI and Oscillometry of Irritant-Induced Asthma After Bronchial Thermoplasty.
    Chest. 2024;165:e27-e31.
    PubMed     Abstract available


  11. ZAEH SE, Eakin MN, Chupp G
    Implementing Antiinflammatory Reliever Strategies in Asthma: The Evolving Paradigm of Asthma Management.
    Chest. 2024;165:250-252.
    PubMed    


  12. MAKRINIOTI H, Bush A
    Can We Test the Function of the Small Airways in Children Outside the Laboratory?
    Chest. 2024;165:241-242.
    PubMed    


  13. LEE AL, Burge AT
    Adding Up the Value of Pulmonary Rehabilitation in COPD: Money, Morbidity, and Mortality.
    Chest. 2024;165:231-232.
    PubMed    


  14. MAHLER DA, Halpin DMG
    Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD.
    Chest. 2024;165:323-332.
    PubMed     Abstract available


  15. CHOI JY, Kim KU, Kim DK, Kim YI, et al
    Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD: A Nationwide Korean Study.
    Chest. 2024;165:313-322.
    PubMed     Abstract available


    January 2024
  16. CHOI H, Han K, Jung JH, Park J, et al
    Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis.
    Chest. 2024 Jan 4:S0012-3692(24)00002-3. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  17. TAJIMA Y, Tashiro T, Furukawa T, Murata K, et al
    Pulmonary Nocardiosis With Endobronchial Involvement Caused by Nocardiaaraoensis.
    Chest. 2024;165:e1-e4.
    PubMed     Abstract available


  18. FARMER MJS, Couillard S, Lastra AC, Ramakrishnan S, et al
    Trailblazing Clinical Trials in Asthma, COPD, Sleep Medicine, and Education and Clinical Practice in 2023.
    Chest. 2024;165:19-21.
    PubMed    


  19. KIM T, Kim H, Kong S, Shin SH, et al
    Association Between Regular Moderate to Vigorous Physical Activity Initiation Following COPD Diagnosis and Mortality: An Emulated Target Trial Using Nationwide Cohort Data.
    Chest. 2024;165:84-94.
    PubMed     Abstract available


    December 2023
  20. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  21. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  22. CRISAFULLI E, Sartori G, Huerta A, Gabarrus A, et al
    Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes.
    Chest. 2023;164:1422-1433.
    PubMed     Abstract available


  23. NON AL, Bailey B, Bhatt SP, Casaburi R, et al
    Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes.
    Chest. 2023;164:1492-1504.
    PubMed     Abstract available


    November 2023
  24. HANSEN S, Sondergaard M, von Bulow A, Bjerrum AS, et al
    Clinical response and remission in severe asthma patients treated with biologic therapies.
    Chest. 2023 Nov 2:S0012-3692(23)05695-7. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  25. BEASLEY R, Cheng SL, Lee KY, Phuong PT, et al
    ICS/Beta(2)-Agonist Reliever Therapy in Adolescents and Adults With Asthma.
    Chest. 2023;164:1081-1083.
    PubMed    


  26. NASSEREDDIN AT, Zayed Y, King RB, Ataya A, et al
    A 28-Year-Old Woman With Nail Discoloration, Recurrent Bronchitis, and Left-Sided Facial Swelling.
    Chest. 2023;164:e135-e138.
    PubMed     Abstract available


  27. BOURBEAU J, Bhutani M, Hernandez P, Aaron SD, et al
    2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD.
    Chest. 2023;164:1159-1183.
    PubMed     Abstract available


  28. LOEBINGER MR, Quint JK, van der Laan R, Obradovic M, et al
    Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis.
    Chest. 2023;164:1115-1124.
    PubMed     Abstract available


  29. MAKIMOTO K, Hogg JC, Bourbeau J, Tan WC, et al
    CT Imaging With Machine Learning for Predicting Progression to COPD in Individuals at Risk.
    Chest. 2023;164:1139-1149.
    PubMed     Abstract available


  30. KIRBY M, Smith BM
    Quantitative CT Scan Imaging of the Airways for Diagnosis and Management of Lung Disease.
    Chest. 2023;164:1150-1158.
    PubMed     Abstract available


    October 2023
  31. LUGOGO NL, Mohan A, Akuthota P, Couillard S, et al
    Are We Ready for Asthma Remission as a Clinical Outcome?
    Chest. 2023;164:831-834.
    PubMed    


  32. CHALMERS JD, Shoemark A
    Inhaled Corticosteroids in COPD and Bronchiectasis: Use Biomarkers Rather Than Disease Labels.
    Chest. 2023;164:809-811.
    PubMed    


  33. RODRIGUEZ-GARCIA C, Candal-Pedreira C, Perez-Rios M, Ruano-Ravina A, et al
    The Challenge of Diagnosing COPD in Individuals Who Have Never Smoked.
    Chest. 2023;164:835-836.
    PubMed    


    September 2023
  34. TZILAS V, Samhouri BF, Hartman TE, Ryu JH, et al
    Unveiling Many Clinicopathologic Entities and Causes Within COPD Using CT Scan.
    Chest. 2023;164:e85-e86.
    PubMed    


  35. BALFOUR HH
    Antivirals for COPD?
    Chest. 2023;164:564-565.
    PubMed    


  36. POLLOCK J, Goeminne PC
    Eosinophils in Bronchiectasis: A U-Turn for Bronchiectasis Management.
    Chest. 2023;164:561-563.
    PubMed    


  37. LINDEN DA, Guo-Parke H, McKelvey MC, Einarsson GG, et al
    Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD: A Randomized Double-Blind Placebo-Controlled Trial.
    Chest. 2023;164:625-636.
    PubMed     Abstract available


    August 2023
  38. SHTEINBERG M, Sibila O, Stein N, Faner R, et al
    Risk of SARS-CoV-2 infection and disease severity among people with bronchiectasis; analysis of three population registries.
    Chest. 2023 Aug 11:S0012-3692(23)05267-4. doi: 10.1016/j.chest.2023.
    PubMed    


  39. MENZIES-GOW AN, Price DB
    Clinical Remission in Severe Asthma: How to Move From Theory to Practice.
    Chest. 2023;164:296-298.
    PubMed    


  40. DE-TORRES JP
    "Another Hole in the Wall": The Importance of Centrilobular Emphysema in Patients With COPD.
    Chest. 2023;164:271-272.
    PubMed    


  41. VINAY V, Verma P, Kumar A, Modi S, et al
    Pulmonary Cavitation With Eosinophilia in a Young Man.
    Chest. 2023;164:e27-e31.
    PubMed     Abstract available


  42. RAOOF S, Shah M, Braman S, Agrawal A, et al
    Lung Imaging in COPD Part 2: Emerging Concepts.
    Chest. 2023;164:339-354.
    PubMed     Abstract available


  43. ZHU J, Zhou D, Wang J, Yang Y, et al
    A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis: A Bidirectional Mendelian Randomization Study.
    Chest. 2023;164:429-440.
    PubMed     Abstract available


  44. DEMKOWICZ BJ, Tu SS, Kesselheim AS, Carrier MA, et al
    Patenting Strategies on Inhaler Delivery Devices.
    Chest. 2023;164:450-460.
    PubMed     Abstract available


    July 2023
  45. GOYAL V, Yerkovich ST, Grimwood K, Marchant JM, et al
    Phenotypic features of pediatric bronchiectasis exacerbations associated with symptom resolution after 14-days of oral antibiotic treatment.
    Chest. 2023 Jul 10:S0012-3692(23)00954-6. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  46. ROBERTS JM, Goyal V, Kularatna S, Chang AB, et al
    The economic burden of bronchiectasis: a systematic review.
    Chest. 2023 Jul 7:S0012-3692(23)00948-0. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  47. PISTENMAA CL, Washko GR
    Chest Imaging of COPD: Bridging the COPD Research Gap With Stop, Look, and Listen.
    Chest. 2023;164:8-10.
    PubMed    


  48. FAIN SB, Comellas AP
    Monitoring Biologic Therapy in Asthma Using Functional Imaging.
    Chest. 2023;164:3-5.
    PubMed    


  49. RAOOF S, Shah M, Make B, Allaqaband H, et al
    Lung Imaging in COPD Part 1: Clinical Usefulness.
    Chest. 2023;164:69-84.
    PubMed     Abstract available


  50. HARPER LJ, Kidambi P, Kirincich JM, Thornton JD, et al
    Health Disparities: Interventions for Pulmonary Disease - A Narrative Review.
    Chest. 2023;164:179-189.
    PubMed     Abstract available


    June 2023
  51. OPPENHEIMER J, Hanania NA, Chaudhuri R, Sagara H, et al
    Clinic versus home spirometry for monitoring lung function in patients with asthma.
    Chest. 2023 Jun 27:S0012-3692(23)00935-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  52. RITCHIE AI, Singayagam A, Mitchell S, Wedzicha JA, et al
    The Effect of Inhaled Corticosteroids on Pneumonia Risk in Patients With COPD-Bronchiectasis Overlap: A UK Population-Based Case-Control Study.
    Chest. 2023 Jun 17:S0012-3692(23)00808-5. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  53. LI Y, Su C, Yan Y, Wang Z, et al
    A 75-Year-Old Man With Irregular Solid Components Within an Emphysematous Bulla.
    Chest. 2023;163:e265-e273.
    PubMed     Abstract available


  54. YAO X, Barochia AV, Levine SJ
    What's on the Horizon for the Targeted Treatment of Type 2-low Asthma?
    Chest. 2023;163:1362-1364.
    PubMed    


  55. COUILLARD S, Cote A
    Predicting On-Biologic Remission in Asthma: Insight From the Airways.
    Chest. 2023;163:1341-1343.
    PubMed    


    May 2023
  56. DE VRIES R, Farzan N, Fabius T, De Jongh FHC, et al
    Prospective Detection of Early Lung Cancer in COPD Patients in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    Chest. 2023 May 18:S0012-3692(23)00754-7. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  57. JERVAN O, Haukeland-Parker S, Gleditsch J, Tavoly M, et al
    The effects of exercise training in patients with persistent dyspnoea after pulmonary embolism: a randomized controlled trial.
    Chest. 2023 May 4:S0012-3692(23)00643-8. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  58. OBA Y
    Data Collection Issues With Mortality Risk of Inhaled Corticosteroids in COPD.
    Chest. 2023;163:e247.
    PubMed    


  59. SAHA BK, Wayne MT, Chenna P
    A 52-Year-Old Woman With a History of Ulcerative Colitis and New Onset Severe Dyspnea.
    Chest. 2023;163:e211-e217.
    PubMed     Abstract available


  60. DIVER S, Green RH
    Improving Outcomes in Difficult Asthma: Watch and Weight.
    Chest. 2023;163:999-1000.
    PubMed    


  61. TURNBULL CD, Thomas RJ
    Seeking Precision: Endotypes and Phenotypes of OSA.
    Chest. 2023;163:1016-1017.
    PubMed    


  62. ROZENBERG D, Maddocks M
    Looking Beyond BMI Classifications With Complementary Assessment of Body Composition in COPD.
    Chest. 2023;163:1003-1004.
    PubMed    


  63. VEGAS SANCHEZ-FERRERO G, San Jose Estepar R
    The Value of Virtual Clinical Trials for the Assessment of the Effect of Acquisition Protocols in Emphysema Quantification.
    Chest. 2023;163:1001-1002.
    PubMed    


  64. MACHADO FVC, Vogelmeier CF, Jorres RA, Watz H, et al
    Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network.
    Chest. 2023;163:1071-1083.
    PubMed     Abstract available


    April 2023
  65. MARTINEZ-GARCIA MA, Mendez R, Olveira C, Giron R, et al
    The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids.
    Chest. 2023 Apr 21:S0012-3692(23)00604-9. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  66. ROCHE SM, Carroll TP, Fraughen DD, McElvaney NG, et al
    Alpha-1 Antitrypsin Deficiency and Smoking Cessation: Tackling the Burden of COPD One Test at a Time?
    Chest. 2023;163:e197.
    PubMed    


  67. MULPURU S, Aaron SD
    Bronchodilator Responsiveness Over Time: Is This Clinically Meaningful in Tobacco-Exposed Individuals?
    Chest. 2023;163:736-737.
    PubMed    


  68. KENDZERSKA T, Gershon AS
    One Size Does Not Fit All: Risk Stratification for COPD Exacerbations.
    Chest. 2023;163:733-735.
    PubMed    


  69. BLAGEV DP
    Comparison Among Different Inhalers in COPD: The Differences Are Too Big and Too Small, and It Matters.
    Chest. 2023;163:731-732.
    PubMed    


  70. HO JK, Safari A, Adibi A, Sin DD, et al
    Generalizability of Risk Stratification Algorithms for Exacerbations in COPD.
    Chest. 2023;163:790-798.
    PubMed     Abstract available


  71. WENG CF, Wu CC, Wu MH, Lin FJ, et al
    Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting beta(2)-Agonists in Patients With COPD.
    Chest. 2023;163:799-814.
    PubMed     Abstract available


  72. HERNANDEZ C, Tukpah AC, Mitchell HM, Rosario NA, et al
    Hospital-Level Care at Home for Patients With Acute Respiratory Disease: A Descriptive Analysis.
    Chest. 2023;163:891-901.
    PubMed     Abstract available


    March 2023
  73. YUAN H, Liu Z, Dong J, Bacharier LB, et al
    The fungal microbiome of the upper airway is associated with future loss of asthma control and exacerbation among children with asthma.
    Chest. 2023 Mar 30:S0012-3692(23)00462-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  74. CHIPPS BE, Israel E, Beasley R, Panettieri RA Jr, et al
    Albuterol-budesonide pressurized metered dose inhaler in patients with mild-to-moderate asthma: results of the DENALI double-blind randomized controlled trial.
    Chest. 2023 Mar 30:S0012-3692(23)00463-4. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  75. COSIO BG, Shafiek H, Mosteiro M, Iglesias A, et al
    Redefining the role of bronchoscopy in the work-up of severe uncontrolled asthma in the era of biologics: a prospective study.
    Chest. 2023 Mar 13:S0012-3692(23)00354-9. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  76. PEREA L, Faner R, Solarat B, Shoemark A, et al
    Low salivary secretory leukocyte protease inhibitor levels are related to airway Pseudomonas aeruginosa infection in Bronchiectasis.
    Chest. 2023 Mar 8:S0012-3692(23)00318-5. doi: 10.1016/j.chest.2023.
    PubMed    


  77. KRISHNAN S, Tan WC, Farias R, Aaron SD, et al
    Impaired spirometry and chronic obstructive pulmonary disease increase the risk of cardiovascular disease: a Canadian cohort study.
    Chest. 2023 Mar 3:S0012-3692(23)00315-X. doi: 10.1016/j.chest.2023.
    PubMed    


  78. PALANI P, Lokeshwaran S, Sunil Kumar K, Girish G, et al
    A 33-Year-Old Woman With Breathing Difficulty, Inspiratory Wheeze, and Hemoptysis.
    Chest. 2023;163:e141-e145.
    PubMed     Abstract available


  79. CELLI B
    Screening for COPD: Challenging the United Sates Preventive Services Task Force Recommendation.
    Chest. 2023;163:481-483.
    PubMed    


  80. HARRIES TH, Russell REK
    Don't Forget to Look Both Ways: The Role of Blood Eosinophil Counts in Identifying Subgroups and Susceptibility in COPD Patients.
    Chest. 2023;163:467-468.
    PubMed    


  81. FORTIS S, Quibrera PM, Comellas AP, Bhatt SP, et al
    Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Chest. 2023;163:502-514.
    PubMed     Abstract available


  82. HUYNH VC, Etruw E, Bok E, Fuhr DP, et al
    Evaluation of an In-Home Virtual Pulmonary Rehabilitation Program for Respiratory Patients Delivered in Response to the COVID Pandemic.
    Chest. 2023;163:529-532.
    PubMed    


  83. LEMASTER WB, Quibrera PM, Couper D, Tashkin DP, et al
    Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.
    Chest. 2023;163:515-528.
    PubMed     Abstract available


  84. FALVO MJ, Sotolongo AM, Osterholzer JJ, Robertson MW, et al
    Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis: A Modified Delphi Study.
    Chest. 2023;163:599-609.
    PubMed     Abstract available


    February 2023
  85. GRAMEGNA A, Narayana JK, Amati F, Stainer A, et al
    Microbial inflammatory networks in bronchiectasis exacerbators with Pseudomonas aeruginosa.
    Chest. 2023 Feb 16:S0012-3692(23)00259-3. doi: 10.1016/j.chest.2023.
    PubMed    


  86. MCINTOSH MJ, Kooner HK, Eddy RL, Wilson A, et al
    CT Mucus Score and 129Xe MRI Ventilation Defects after 2.5-years anti-IL-5Ralpha in Eosinophilic Asthma.
    Chest. 2023 Feb 11:S0012-3692(23)00189-7. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  87. MOERMANS C, Brion C, Bock G, Graff S, et al
    Sputum Type 2 markers could predict remission in severe asthma treated with anti-Interleukin-5.
    Chest. 2023 Feb 3:S0012-3692(23)00169-1. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  88. RIBLET NBV, Watts BV
    Another Reason to Quit Smoking: Results of a Prospective Study Examining Smoking, COPD, and Suicide.
    Chest. 2023;163:259-261.
    PubMed    


  89. ADVIENTO BA, Regan EA, Make BJ, Han MK, et al
    Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort.
    Chest. 2023;163:292-302.
    PubMed     Abstract available


    January 2023
  90. SHIRAISHI Y, Tanabe N, Shimizu K, Oguma A, et al
    Stronger associations of centrilobular than paraseptal emphysema with longitudinal changes in diffusing capacity and mortality in COPD.
    Chest. 2023 Jan 31:S0012-3692(23)00166-6. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  91. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
    A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled feasibility trial.
    Chest. 2023 Jan 14:S0012-3692(23)00117-4. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  92. DIXON AE, Poynter ME, Garrow OJ, Kaminsky DA, et al
    Peripheral airway dysfunction in obesity and obese asthma.
    Chest. 2023 Jan 4:S0012-3692(23)00005-3. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  93. MAJID A, Rosenberg BJ, Ospina Delgado D, Gangadharan S, et al
    Bronchoscopic Lung Volume Reduction After Surgical Fissure Completion Is Not Ready for Prime Time.
    Chest. 2023;163:e48-e49.
    PubMed    


  94. MARCINIUK DD, Calzetta L
    Inhaled Corticosteroids and COPD: 25 Years Later and We Are Still Not There.
    Chest. 2023;163:8-9.
    PubMed    


  95. WONG C, Martinez-Garcia MA
    Randomized Clinical Trials of Inhaled Antibiotics in Bronchiectasis: Cause for Optimism?
    Chest. 2023;163:3-5.
    PubMed    


  96. GARNER O, Hanania NA
    Is Extracorporeal Membrane Oxygenation More Than Just Salvage Therapy in Acute Life-Threatening Asthma?
    Chest. 2023;163:1-2.
    PubMed    


  97. CHEN H, Deng ZX, Sun J, Huang Q, et al
    Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.
    Chest. 2023;163:100-114.
    PubMed     Abstract available


  98. CHOI B, Adan N, Doyle TJ, San Jose Estepar R, et al
    Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.
    Chest. 2023;163:164-175.
    PubMed     Abstract available


    December 2022
  99. SUISSA S
    Inhaled Corticosteroids and Mortality in COPD: Biases in Randomized Trials.
    Chest. 2022;162:e333-e334.
    PubMed    


  100. RAMAKRISHNAN S
    Maintenance Pulmonary Rehabilitation: Can We Keep the Good Times Rolling?
    Chest. 2022;162:1227-1228.
    PubMed    


  101. FREI A, Radtke T, Dalla Lana K, Brun P, et al
    Effectiveness of a Long-term Home-Based Exercise Training Program in Patients With COPD After Pulmonary Rehabilitation: A Multicenter Randomized Controlled Trial.
    Chest. 2022;162:1277-1286.
    PubMed     Abstract available


    November 2022
  102. ABADI E, Jadick G, Lynch DA, Segars WP, et al
    Emphysema quantifications with CT: Assessing the effects of acquisition protocols and imaging parameters using virtual imaging trials.
    Chest. 2022 Nov 30:S0012-3692(22)04203-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  103. ZHANG RL, Pan CX, Tang CL, Cen LJ, et al
    Motile ciliary disorders of the nasal epithelium in adults with bronchiectasis.
    Chest. 2022 Nov 23:S0012-3692(22)04192-7. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  104. CAZES N, Briquet A
    COPD Risk After Military Service: Let's Go Further Before Concluding.
    Chest. 2022;162:e287-e288.
    PubMed    


  105. SMITH KS, Lee SA, Albers BK, Stevens EL, et al
    A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation.
    Chest. 2022;162:e265-e271.
    PubMed     Abstract available


  106. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.
    PubMed    


  107. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.
    PubMed    


  108. CHO EE, Gershon AS
    Single vs Multiple Inhaler Triple Therapy in the COPD Population.
    Chest. 2022;162:947-948.
    PubMed    


  109. ALCAZAR-NAVARRETE B, Jamart L, Sanchez-Covisa J, Juarez M, et al
    Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Chest. 2022;162:1017-1029.
    PubMed     Abstract available


  110. NEDER JA, Kirby M, Santyr G, Pourafkari M, et al
    V/Q Mismatch: A Novel Target for COPD Treatment.
    Chest. 2022;162:1030-1047.
    PubMed     Abstract available


    October 2022
  111. MAKRINIOTI H, Camargo CA Jr, Jartti T, Hasegawa K, et al
    Toward Precision Epidemiology in Bronchiolitis.
    Chest. 2022;162:744-746.
    PubMed    


  112. TRUPIN L, Schmajuk G, Ying D, Yelin E, et al
    Military Service and COPD Risk.
    Chest. 2022;162:792-795.
    PubMed    


    September 2022
  113. ZAKRAJSEK JK, Min SJ, Ho PM, Kiser TH, et al
    Extracorporeal Membrane Oxygenation (ECMO) for Refractory Asthma Exacerbations with Respiratory Failure.
    Chest. 2022 Sep 30. pii: S0012-3692(22)03899-5. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  114. KHASAWNEH M, Leon ME, Urbine D
    A 65-Year-Old Woman With Intractable Cough.
    Chest. 2022;162:e123-e126.
    PubMed     Abstract available


  115. SODHI A, Pisani M, Glassberg MK, Bourjeily G, et al
    Sex and Gender in Lung Disease and Sleep Disorders: A State-of-the-Art Review.
    Chest. 2022;162:647-658.
    PubMed     Abstract available


  116. DIAZ DEL VALLE F, Zakrajsek JK, Min SJ, Koff PB, et al
    Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation.
    Chest. 2022;162:556-568.
    PubMed     Abstract available


    August 2022
  117. VICENDESE D, Yerkovich S, Grimwood K, Valery PC, et al
    Long-term azithromycin in children with bronchiectasis unrelated to cystic fibrosis: treatment effects over time.
    Chest. 2022 Aug 25. pii: S0012-3692(22)03684.
    PubMed     Abstract available


  118. SHAFIQ M, Polhemus E, Perkins R, Forth V, et al
    Bilateral Bronchoscopic Lung Volume Reduction After Surgical Fissure Completion.
    Chest. 2022;162:e73-e75.
    PubMed     Abstract available


  119. ATWOOD CE, Bhutani M, Ospina MB, Rowe BH, et al
    Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator: A Randomized Clinical Trial.
    Chest. 2022;162:321-330.
    PubMed     Abstract available


    July 2022
  120. GUAN WJ, Xu JF, Luo H, Xu XX, et al
    A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection.
    Chest. 2022 Jul 18. pii: S0012-3692(22)01247-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  121. MORRIS TA, Fernandes TM, Channick R
    How we do it: evaluation of dyspnea and exercise intolerance after acute pulmonary embolism.
    Chest. 2022 Jul 2. pii: S0012-3692(22)01215-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  122. HAHN DL
    Azithromycin Response in Uncontrolled Asthma in Children: Binary or Continuous?
    Chest. 2022;162:e61.
    PubMed    


  123. LUGOGO N, Mohan A
    Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?
    Chest. 2022;162:4-5.
    PubMed    


  124. THOMAS D, Gibson PG
    Long-Term, Low-Dose Azithromycin for Uncontrolled Asthma in Children.
    Chest. 2022;162:27-29.
    PubMed    


  125. SPRUIT MA, Tan WC
    Physical Frailty Makes Matters Worse in People With COPD.
    Chest. 2022;162:25-26.
    PubMed    


  126. GUERRA S
    Nonobstructive Chronic Bronchitis: A Sentinel for Risk of Premature Death in Smokers?
    Chest. 2022;162:19-21.
    PubMed    


  127. KANJ AN, Ryu JH
    Severe Airflow Obstruction From Constrictive (Obliterative) Bronchiolitis in Paraneoplastic Autoimmune Multiorgan Syndrome.
    Chest. 2022;162:179-183.
    PubMed    


  128. FORTIS S, Shannon ZK, Garcia CJ, Guillamet RV, et al
    Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysis.
    Chest. 2022;162:92-100.
    PubMed     Abstract available


  129. CHERIAN SV, Patel D, Machnicki S, Naidich D, et al
    Algorithmic Approach to the Diagnosis of Organizing Pneumonia: A Correlation of Clinical, Radiologic, and Pathologic Features.
    Chest. 2022;162:156-178.
    PubMed     Abstract available


  130. HUG S, Cavalheri V, Gucciardi DF, Hill K, et al
    An Evaluation of Factors That Influence Referral to Pulmonary Rehabilitation Programs Among People With COPD.
    Chest. 2022;162:82-91.
    PubMed     Abstract available


    June 2022
  131. VAES AW, Spruit MA, Koolen EH, Antons JC, et al
    "Can Do, Do Do" Quadrants and 6-Year All-Cause Mortality in Patients With COPD.
    Chest. 2022;161:1494-1504.
    PubMed     Abstract available


    May 2022
  132. SINGH J, Randev S, Kumar P, Mahajan V, et al
    A 16-Year-Old-Girl With Asthma, Palpable Purpura, and Hypereosinophilia.
    Chest. 2022;161:e305-e308.
    PubMed     Abstract available


  133. HUDLER AC, Sharma S
    Understanding the Genetics of Asthma-COPD Overlap.
    Chest. 2022;161:1125-1126.
    PubMed    


  134. LEE SY, Nyunt MSZ, Gao Q, Gwee X, et al
    Co-occurrence of Physical Frailty and COPD and Association With Disability and Mortality: Singapore Longitudinal Ageing Study.
    Chest. 2022;161:1225-1238.
    PubMed     Abstract available


  135. ESTHER CR JR, O'Neal WK, Anderson WH, Kesimer M, et al
    Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
    Chest. 2022;161:1239-1249.
    PubMed     Abstract available


  136. IYER AS, Sullivan DR, Lindell KO, Reinke LF, et al
    The Role of Palliative Care in COPD.
    Chest. 2022;161:1250-1262.
    PubMed     Abstract available


    April 2022
  137. CLARK SM, Parker AM, Ataya A
    A 31-Year-Old Man With Asthma, Chest Discomfort, and Shortness of Breath.
    Chest. 2022;161:e209-e212.
    PubMed     Abstract available


  138. PAUL TK, Kim JS
    Can Interstitial Lung Abnormalities Explain a High FVC in a Smoker With Emphysema?
    Chest. 2022;161:872-873.
    PubMed    


  139. YAWN BP
    Developing and Disseminating Evidence to Support Enhanced Spirometry Use in Primary Care Diagnosis of Asthma and COPD.
    Chest. 2022;161:865-866.
    PubMed    


  140. POULOSE V
    Classification of Small Airways.
    Chest. 2022;161:e249.
    PubMed    


  141. MASON SE, Moreta-Martinez R, Labaki WW, Strand MJ, et al
    Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers.
    Chest. 2022;161:960-970.
    PubMed     Abstract available


  142. YEE N, Markovic D, Buhr RG, Fortis S, et al
    Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
    Chest. 2022;161:949-959.
    PubMed     Abstract available


    March 2022
  143. MCINTOSH MJ, Kooner HK, Eddy RL, Jeimy S, et al
    Asthma control, Airway mucus and (129)Xe MRI ventilation after a single Benralizumab dose.
    Chest. 2022 Mar 10. pii: S0012-3692(22)00424-X. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  144. MOSS MH, Lugogo NL, Castro M, Hanania NA, et al
    Results of a phase 2b trial with GB001, a DP2 antagonist, in moderate-to-severe eosinophilic asthma.
    Chest. 2022 Mar 3. pii: S0012-3692(22)00405-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available



  145. Correction to Figure in: Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
    Chest. 2022;161:863.
    PubMed    


  146. NOLAN CM, Polgar O, Schofield SJ, Patel S, et al
    Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study.
    Chest. 2022;161:728-737.
    PubMed     Abstract available


  147. WAN ES, Hokanson JE, Regan EA, Young KA, et al
    Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Chest. 2022;161:651-661.
    PubMed     Abstract available


  148. WOUTERS EFM, Breyer-Kohansal R
    Spirometry: The Indefinite Search for Gold.
    Chest. 2022;161:593-594.
    PubMed    


  149. ROSE EK, O'Connor J
    Addressing Advance Care Planning in Patients With COPD.
    Chest. 2022;161:676-683.
    PubMed     Abstract available


  150. SYED N, Ryu MH, Dhillon S, Schaeffer MR, et al
    Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD: A Randomized, Placebo-Controlled, Crossover Trial.
    Chest. 2022;161:662-675.
    PubMed     Abstract available


    February 2022
  151. GARNER O, Ramey JS, Hanania NA
    Management of Life-Threatening Asthma: Severe Asthma Series.
    Chest. 2022 Feb 23. pii: S0012-3692(22)00395-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  152. SHER LD, Wechsler ME, Rabe KF, Maspero JF, et al
    Dupilumab reduces oral corticosteroid use in patients with corticosteroid-dependent severe asthma: An analysis of the phase 3, open-label extension TRAVERSE trial.
    Chest. 2022 Feb 22. pii: S0012-3692(22)00388-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  153. GHIMIRE JJ, Jat KR, Sankar J, Lodha R, et al
    Azithromycin for Poorly Controlled Asthma in Children: A randomized controlled trial.
    Chest. 2022 Feb 21. pii: S0012-3692(22)00293-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  154. VAMEGHESTAHBANATI M, Hiura GT, Barr RG, Sieren JC, et al
    CT-Assessed Dysanapsis and Airflow Obstruction in Early and Mid Adulthood.
    Chest. 2022;161:389-391.
    PubMed    


    January 2022
  155. JOHN C, Guyatt AL, Shrine N, Packer R, et al
    Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap.
    Chest. 2022 Jan 29. pii: S0012-3692(22)00198-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  156. KOVACS G, Avian A, Bachmaier G, Troester N, et al
    Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach.
    Chest. 2022 Jan 26. pii: S0012-3692(22)00192-1. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  157. SURI R, Macinko J, Inkelas M, Needleman J, et al
    The relationship between insurance status and the Affordable Care Act on asthma outcomes among low-income US adults.
    Chest. 2022 Jan 15. pii: S0012-3692(22)00046-0. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  158. CHIAPPETTA M, Sassorossi C, Lococo F, Lorusso R, et al
    Intrapleural Foreign Body in a Critically Ill Patient: What Can We Do?
    Chest. 2022;161:e51-e53.
    PubMed    


  159. MAJUMDAR U, Hatipoglu U, Stoller JK
    A 21-Year-Old Man With Dyspnea, Wheezing, and Cough.
    Chest. 2022;161:e13-e17.
    PubMed     Abstract available


    December 2021
  160. AZAM MB, Chhabra S, Agrawal S, Sharma P, et al
    A 37-Year-Old Man With Bronchial Asthma and Unexplained Hypoxemia.
    Chest. 2021;160:e633-e638.
    PubMed     Abstract available


  161. HILL K, Dolmage TE
    Take a Deep Breath: More Support for Noninvasive Ventilation During Exercise in People With COPD.
    Chest. 2021;160:1991-1992.
    PubMed    


  162. DENNIS CJ, Menadue C, Schneeberger T, Leitl D, et al
    Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD.
    Chest. 2021;160:2066-2079.
    PubMed     Abstract available


  163. BURTIN C, Mohan D, Troosters T, Watz H, et al
    Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.
    Chest. 2021;160:2080-2100.
    PubMed     Abstract available


    November 2021
  164. PINSKY PF, Lynch DA, Gierada DS
    Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04413-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  165. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  166. CHUPP G, Kline JN, Khatri SB, McEvoy C, et al
    Bronchial Thermoplasty in Severe Asthmatics At 5 Years: The PAS2 Study.
    Chest. 2021 Nov 10. pii: S0012-3692(21)04274-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  167. MENON AA, Putman RK, Sanders JL, Hino T, et al
    Interstitial Lung Abnormalities, Emphysema and Spirometry in Smokers.
    Chest. 2021 Nov 3. pii: S0012-3692(21)04260-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  168. YAMADA J, Shin Cheung JL, Gagne M, Spiegel-Feld C, et al
    Barriers and Enablers to Objective Testing for Asthma and COPD in Primary Care: A Systematic Review Using the Theoretical Domains Framework.
    Chest. 2021 Nov 2. pii: S0012-3692(21)04256-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  169. BARN P, Rideout KL, Lo W, Josey D, et al
    Better together: Launching and nurturing a Community Stakeholder Committee to enhance care and research for asthma and COPD.
    Chest. 2021 Nov 2. pii: S0012-3692(21)04254-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  170. GOEL K, Maleki-Fischbach M, George MP, Kim D, et al
    A 56-Year-Old Man With Emphysema, Rash, and Arthralgia.
    Chest. 2021;160:e513-e518.
    PubMed     Abstract available


  171. OKEREKE J, Malin M, Koo P
    A 31-Year-Old Pregnant Woman With Asthma, Presenting With Worsening Dyspnea, Wheeze, and Hoarseness.
    Chest. 2021;160:e507-e512.
    PubMed     Abstract available



  172. Correction to Funding/Support in: International Severe Asthma Registry: Mission Statement.
    Chest. 2021;160:1989.
    PubMed    



  173. Correction to Funding/Support in: Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.
    Chest. 2021;160:1989.
    PubMed    


  174. GAURAV R, Anderson DR, Radio SJ, Bailey KL, et al
    IL-33 Depletion in COVID-19 Lungs.
    Chest. 2021;160:1656-1659.
    PubMed    


  175. LAHOUSSE L
    Personalizing Oral Corticosteroid Dose in Severe COPD Exacerbations.
    Chest. 2021;160:1581-1582.
    PubMed    


  176. HILL NS, Criner GJ, Branson RD, Celli BR, et al
    Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic
    Chest. 2021;160:e389-e397.
    PubMed     Abstract available


  177. GERSHON AS, Pequeno P, Alberga Machado A, Aaron SD, et al
    Factors Associated With Nonreceipt of Recommended COPD Medications: A Population Study.
    Chest. 2021;160:1670-1680.
    PubMed     Abstract available


  178. LI L, Zhao N, Ma X, Sun F, et al
    Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial.
    Chest. 2021;160:1660-1669.
    PubMed     Abstract available


    October 2021
  179. SAFIRI S, Carson-Chahhoud K, Karamzad N, Sullman MJM, et al
    Prevalence, deaths and disability-adjusted-life-years (DALYs) due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019.
    Chest. 2021 Oct 23. pii: S0012-3692(21)04206-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  180. RUPANI H, Kent BD
    Using FeNO Measurement in Clinical Asthma Management.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04109-X. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  181. MENDEZ R, Feced L, Alcaraz-Serrano V, Gonzalez-Jimenez P, et al
    Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
    Chest. 2021 Oct 14. pii: S0012-3692(21)04101-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  182. LEUNG C, Sin DD
    Asthma-COPD Overlap: What are the important questions?
    Chest. 2021 Oct 6. pii: S0012-3692(21)04078-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  183. ZAFAR MA, Sengupta R, Bates A, Woods JC, et al
    Oral Positive Expiratory Pressure Device for Excessive Dynamic Airway Collapse Caused by Emphysema.
    Chest. 2021;160:e333-e337.
    PubMed     Abstract available


  184. BERTELS X, Lahousse L
    Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function Decline.
    Chest. 2021;160:1160-1162.
    PubMed    


  185. KANTAR A
    Bronchiectasis in Australian First Nations Children: Looking Inside the Gunyah.
    Chest. 2021;160:1153-1154.
    PubMed    


  186. AKUTHOTA P, Jackson DJ, Wechsler ME
    Introducing the Severe Asthma Series of Invited Reviews.
    Chest. 2021;160:1151-1152.
    PubMed    


  187. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    PubMed     Abstract available


  188. WANG MT, Lai JH, Huang YL, Liou JT, et al
    Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting beta2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting beta2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity S
    Chest. 2021;160:1255-1270.
    PubMed     Abstract available


  189. GLASSBERG MK, Csete I, Simonet E, Elliot SJ, et al
    Stem Cell Therapy for COPD: Hope and Exploitation.
    Chest. 2021;160:1271-1281.
    PubMed     Abstract available


    September 2021
  190. ZOU RH, Bon J
    Reduced Dlco in GOLD I COPD: Moving Towards a Multidimensional Approach to Risk Stratification.
    Chest. 2021;160:791-792.
    PubMed    


  191. YOSHIDA M, Miyahara Y, Orimo K, Kono N, et al
    Eosinophil Extracellular Traps in the Casts of Plastic Bronchitis Associated With Influenza Virus Infection.
    Chest. 2021;160:854-857.
    PubMed    


  192. DE-TORRES JP, O'Donnell DE, Marin JM, Cabrera C, et al
    Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.
    Chest. 2021;160:872-878.
    PubMed     Abstract available


  193. WU TD, Fawzy A, Brigham E, McCormack MC, et al
    Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study.
    Chest. 2021;160:1026-1034.
    PubMed     Abstract available


    August 2021
  194. HEIDORN MW, Steck S, Muller F, Trobs SO, et al
    Forced expiratory volume in one second predicts cardiac status and outcome in chronic heart failure.
    Chest. 2021 Aug 17. pii: S0012-3692(21)03682.
    PubMed     Abstract available


  195. TATAH J, Keen JL, Prisco SZ, Pritzker M, et al
    Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease.
    Chest. 2021 Aug 2. pii: S0012-3692(21)03610-2. doi: 10.1016/j.chest.2021.07.2159
    PubMed    


  196. KLINGER JR
    Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
    Chest. 2021;160:409-410.
    PubMed    


  197. DECATO TW, Hegewald MJ
    Diffusing Capacity, the Too Often Ignored Lung Function Test in COPD.
    Chest. 2021;160:389-390.
    PubMed    


  198. SOLED DR, Thurber E, Amundson B, Schissel SL, et al
    Payment Reform as a Means of Achieving Justice: A Look at Pulmonary Rehabilitation Reimbursement.
    Chest. 2021;160:786-788.
    PubMed    


  199. CASANOVA C, Gonzalez-Davila E, Martinez-Gonzalez C, Cosio BG, et al
    Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex.
    Chest. 2021;160:481-490.
    PubMed     Abstract available


  200. MAHLER DA, Halpin DMG
    Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD.
    Chest. 2021;160:491-498.
    PubMed     Abstract available


    July 2021
  201. CHONG WH, Saha B, Ibrahim A, Smith TC, et al
    Dyspnea in a 57-Year-Old Man With Recent Viral Illness.
    Chest. 2021;160:e19-e24.
    PubMed     Abstract available


  202. PISTELLI F, Carrozzi L
    Slow Is Better Than Fast?: Usefulness of FEV1/Slow Vital Capacity <0.7 in the Identification of Asymptomatic Ever Smokers at Risk for COPD.
    Chest. 2021;160:7-8.
    PubMed    


  203. DEMEO DL
    Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
    Chest. 2021;160:104-113.
    PubMed     Abstract available


  204. FORTIS S, Comellas AP, Bhatt SP, Hoffman EA, et al
    Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
    Chest. 2021;160:94-103.
    PubMed     Abstract available


    June 2021
  205. BUTLER SJ, Gershon AS, Goodridge DM
    Perspectives on Palliative Care in COPD.
    Chest. 2021;159:2133-2134.
    PubMed    


  206. DIVO M
    Increased Health Care Use: With or From COPD?
    Chest. 2021;159:2131-2132.
    PubMed    


  207. SHEN E, Lee JS, Mularski RA, Crawford P, et al
    COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use.
    Chest. 2021;159:2233-2243.
    PubMed     Abstract available


  208. SERBAN KA, Pratte KA, Bowler RP
    Protein Biomarkers for COPD Outcomes.
    Chest. 2021;159:2244-2253.
    PubMed     Abstract available


  209. FU Y, Mason A, Boland AC, Linklater G, et al
    Palliative Care Needs and Integration of Palliative Care Support in COPD: A Qualitative Study.
    Chest. 2021;159:2222-2232.
    PubMed     Abstract available


  210. GAFFNEY AW, Hawks L, Bor D, White AC, et al
    National Trends and Disparities in Health Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018.
    Chest. 2021;159:2173-2182.
    PubMed     Abstract available


    May 2021
  211. CHANDRA D, Gupta A, Kinney GL, Fuhrman CR, et al
    The Association between Lung Hyperinflation and Coronary Artery Disease in Smokers.
    Chest. 2021 May 7. pii: S0012-3692(21)00889-8. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  212. CHONG WH, Saha B, Shkolnik B
    Persistent Dyspnea in a 74-Year-Old Man With Normal Spirometry and Lung Volumes.
    Chest. 2021;159:e303-e307.
    PubMed     Abstract available


  213. HAZELETT BN, Paton A, Majid A, Schreefer K, et al
    Nurse Coordinator Roles and Responsibilities for Bronchoscopic Lung Volume Reduction With Endobronchial Valves.
    Chest. 2021;159:2090-2098.
    PubMed     Abstract available


  214. NYBERG A, Martin M, Saey D, Milad N, et al
    Effects of Low-Load/High-Repetition Resistance Training on Exercise Capacity, Health Status, and Limb Muscle Adaptation in Patients With Severe COPD: A Randomized Controlled Trial.
    Chest. 2021;159:1821-1832.
    PubMed     Abstract available


    April 2021
  215. DAY K, Ostridge K, Conway J, Cellura D, et al
    Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD.
    Chest. 2021;159:1391-1399.
    PubMed     Abstract available


  216. SAEED GJ, Valero-Elizondo J, Mszar R, Grandhi GR, et al
    Prevalence and Disparities in Influenza Vaccination Among Patients With COPD in the United States.
    Chest. 2021;159:1411-1414.
    PubMed    


  217. ZAFARI Z, Li S, Eakin MN, Bellanger M, et al
    Projecting Long-term Health and Economic Burden of COPD in the United States.
    Chest. 2021;159:1400-1410.
    PubMed     Abstract available


    February 2021
  218. VIZZA CD, Hoeper MM, Huscher D, Pittrow D, et al
    Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.
    Chest. 2021 Feb 10. pii: S0012-3692(21)00272-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


    November 2020
  219. YOUNG RP, Hopkins RJ, Gamble GD, Silvestri GA, et al
    Incorporating baseline lung function in lung cancer screening: Does a "lung health check" help predict outcomes?
    Chest. 2020 Nov 7. pii: S0012-3692(20)35129-1. doi: 10.1016/j.chest.2020.
    PubMed    


    August 2020
  220. KAVANAGH JE, Hearn AP, Dhariwal J, Grainne d'Ancona, et al
    Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
    Chest. 2020 Aug 31. pii: S0012-3692(20)34313.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.